Parkinson Disease

Parkinson disease is a progressive neurological disorder that primarily affects movement. It develops gradually, often starting with a barely noticeable tremor in one hand. But as the disease progresses, it can cause stiffness, slowing of movement (bradykinesia), and balance problems. While there is currently no cure for Parkinson disease, significant advancements have been made in understanding its mechanisms and developing treatments that can help manage symptoms and improve the lives of those affected. 

Parkinson disease is a long-term, progressive brain disorder that affects the central nervous system. It is primarily characterised by the degeneration of neurons in the substantia nigra, a region of the midbrain responsible for producing dopamine. Dopamine acts as a chemical messenger, transmitting signals between nerve cells that control movement, coordination, and other functions. As these dopamine-producing neurons die or become impaired, the amount of dopamine in the brain decreases. This dopamine deficiency disrupts the normal communication between brain cells involved in motor control, leading to the hallmark movement-related symptoms of Parkinson disease.

Beyond the loss of dopamine, Parkinson disease is also associated with the abnormal accumulation of a protein called alpha-synuclein within brain cells, forming structures known as Lewy bodies. While the exact role of Lewy bodies in the development and progression of Parkinson is still being investigated, their presence is a key pathological feature of the disease and is thought to contribute to both the motor and non-motor symptoms. The progressive nature of Parkinson means that symptoms typically worsen over time, although the rate of progression can vary considerably among individuals.

Parkinson disease is a relatively common neurodegenerative disorder. Globally, it is estimated that more than 10 million people are living with Parkinson disease. The prevalence is generally higher in older populations, with most people developing the condition after the age of 60.

While the underlying pathology of dopamine depletion and alpha-synuclein accumulation is common to all individuals with Parkinson disease, there are some variations and classifications sometimes used to describe the presentation and progression of the condition:

Idiopathic Parkinson Disease: This is the most common form, where the cause of the disease is unknown.

Early-Onset Parkinson Disease: This refers to Parkinson diagnosed before the age of 50. It may have a stronger genetic component and can sometimes progress more slowly.

Young-Onset Parkinson Disease: This is diagnosed before the age of 40 and is even less common.

Atypical Parkinsonism (Parkinson-Plus Syndromes): These are conditions that share some symptoms with Parkinson disease but have additional features and often progress differently. Examples include:

• Multiple System Atrophy (MSA): Characterised by a combination of parkinsonian features, cerebellar dysfunction (affecting coordination and balance), and autonomic dysfunction (affecting blood pressure, bladder control, etc.).
• Progressive Supranuclear Palsy (PSP): Often involves balance problems with a tendency to fall backwards, difficulty with eye movements, and cognitive changes.
• Corticobasal Degeneration (CBD): Can present with asymmetrical rigidity and slowness, loss of function in one limb, and cognitive and visual-spatial difficulties.
• Lewy Body Dementia (LBD): Characterised by fluctuations in alertness and cognition, visual hallucinations, and parkinsonian symptoms. In LBD, cognitive problems often appear earlier than or alongside motor symptoms, whereas in Parkinson disease dementia, cognitive issues typically develop later.

The exact cause of Parkinson disease is not fully understood, but it is believed to result from a complex interplay of genetic and environmental factors. Research suggests that the following may play a role:

Genetic Factors: While most cases of Parkinson are sporadic (occurring in individuals with no family history of the disease), genetic mutations have been identified in a small percentage of cases, particularly in early-onset Parkinson. Several genes have been linked to an increased risk, including SNCA (encoding alpha-synuclein), LRRK2, PARK7 (DJ-1), PINK1, and PRKN (parkin).

Environmental Factors: Exposure to certain environmental toxins, such as pesticides and herbicides, has been suggested as a potential risk factor in some studies, although the evidence is not conclusive. Head injury has also been implicated as a possible contributing factor in some cases.

Lewy Bodies: As mentioned earlier, the presence of Lewy bodies, abnormal clumps of alpha-synuclein protein in the brain, is a hallmark of Parkinson disease. The role of alpha-synuclein and why it misfolds and aggregates is an active area of research.

Oxidative Stress: This is an imbalance between free radicals and antioxidants in the body. Some research suggests that oxidative stress may contribute to the damage of dopamine-producing neurons in Parkinson disease.

Mitochondrial Dysfunction: Mitochondria are the "powerhouses" of cells. Dysfunction in mitochondria has been observed in Parkinson disease, potentially leading to energy deficits in brain cells.

Inflammation: Chronic inflammation in the brain may also play a role in the neurodegenerative process in Parkinson disease.

The symptoms of Parkinson disease are varied and can affect movement (motor symptoms) as well as other bodily functions (non-motor symptoms). The classic motor symptoms, often referred to as the cardinal signs of Parkinson, include:

• Tremor: Involuntary shaking, usually starting in a limb, often a hand or fingers (pill-rolling tremor). It is most prominent at rest and tends to lessen during voluntary movement.
• Rigidity: Stiffness or inflexibility of the limbs and trunk, making movement difficult. It can be described as a "cogwheel rigidity" when the limb is passively moved, due to the jerky release of resistance.
• Bradykinesia: Slowness of movement. This can manifest as difficulty initiating movement, reduced facial expressions (mask-like face), decreased blinking, and a shuffling gait with reduced arm swing.
• Postural Instability: Impaired balance and coordination, leading to an increased risk of falls. This often develops later in the course of the disease.

In addition to these motor symptoms, Parkinson disease can also cause a wide range of non-motor symptoms, which can sometimes precede the motor symptoms and significantly impact quality of life:

• Loss of Smell (Anosmia): A reduced or complete inability to smell.
• Sleep Disturbances: Including insomnia, restless legs syndrome, and REM sleep behaviour disorder (acting out dreams).
• Constipation: Problems with bowel movements.
• Mood Disorders: Depression, anxiety, and apathy (lack of motivation).
• Cognitive Impairment: Difficulties with memory, attention, planning, and decision-making. Parkinson disease dementia can develop in some individuals later in the course of the illness.
• Speech Changes (Dysarthria): Soft, monotone, or mumbled speech.
• Swallowing Difficulties (Dysphagia): Problems with chewing and swallowing.
• Fatigue: Persistent tiredness not relieved by rest.
• Pain: Muscle aches, joint pain, or neuropathic pain.
• Lightheadedness or Dizziness (Orthostatic Hypotension): A drop in blood pressure upon standing.
• Visual Disturbances: Blurred vision or other visual changes.

The specific symptoms and their severity can vary greatly from person to person, and not everyone with Parkinson will experience all of these symptoms. The progression of the disease is also highly individualised.

Diagnosing Parkinson disease can be challenging as there is no single definitive test. The diagnosis is primarily based on a neurologist's clinical assessment, which involves a thorough medical history and a detailed neurological examination.

• Medical History: The doctor will ask about the onset and progression of symptoms, family history of Parkinson or other neurological disorders, and exposure to any potential risk factors.
• Neurological Examination: This includes evaluating motor symptoms such as tremor, rigidity, bradykinesia, and balance. The neurologist will also assess non-motor symptoms, speech, and cognitive function.
• Response to Levodopa: Levodopa is a medication that converts to dopamine in the brain and is often effective in improving motor symptoms of Parkinson. A positive response to levodopa can support the diagnosis.
• DaTscan: This is a type of brain imaging scan that measures the level of dopamine transporters in the brain. Reduced uptake can indicate a loss of dopamine-producing neurons, supporting the diagnosis of Parkinsonian syndromes. However, it cannot distinguish between Parkinson disease and atypical parkinsonism.
• Magnetic Resonance Imaging (MRI): While MRI is usually normal in Parkinson disease, it may be used to rule out other conditions that can mimic Parkinsonian symptoms, such as stroke, brain tumours, or hydrocephalus.
• Blood Tests: Blood tests are typically done to exclude other medical conditions that might be causing similar symptoms.

While there is currently no cure for Parkinson disease, various treatments are available to help manage symptoms and improve quality of life. Treatment strategies typically involve a combination of medications, lifestyle modifications, and therapies.

Medications: The primary goal of medication is to increase dopamine levels in the brain or mimic its effects. Common medications include:

• Levodopa: This is the most effective medication for controlling motor symptoms. It is converted to dopamine in the brain. It is often combined with carbidopa (e.g., Syndopa Plus) to prevent the breakdown of levodopa in the bloodstream before it reaches the brain, reducing side effects.
• Dopamine Agonists: These drugs mimic the effects of dopamine in the brain. Examples include pramipexole, ropinirole, and rotigotine (patch). They can be used alone or in combination with levodopa.
• MAO-B Inhibitors: These drugs (e.g., selegiline, rasagiline) block an enzyme that breaks down dopamine in the brain, helping to increase dopamine levels.
• COMT Inhibitors: These medications (e.g., entacapone, tolcapone) help to prevent the breakdown of levodopa, making it more effective and prolonging its effects.
• Amantadine: This drug can help with dyskinesia (involuntary movements that can occur as a side effect of long-term levodopa use) and tremor.
• Anticholinergics: These medications like trihexyphenidyl (Brand available: Pacitane) and benztropine can help reduce tremor and rigidity, but they can have significant side effects, particularly in older adults.

Deep Brain Stimulation (DBS): This is a surgical procedure for individuals with advanced Parkinson disease whose symptoms are not adequately controlled by medication. It involves implanting electrodes in specific areas of the brain and connecting them to a neurostimulator (similar to a pacemaker) implanted in the chest. The neurostimulator sends electrical impulses to the brain, which can help to reduce motor symptoms such as tremor, rigidity, and slowness.

Physical Therapy: Exercises can help maintain mobility, balance, and flexibility.

Occupational Therapy: Therapists can help individuals adapt daily activities to their abilities and provide aids and strategies to improve independence.

Speech Therapy: Can help with speech and swallowing difficulties.

Lifestyle Modifications: Regular exercise, a healthy diet, and adequate sleep are important for overall well-being.

The choice of treatment and its timing depends on the individual's symptoms, age, overall health, and response to medications. Treatment plans are often adjusted over time as the disease progresses.

While the exact cause of Parkinson disease is unknown, several factors have been associated with an increased risk of developing the condition:

• Age: Age is the strongest risk factor. The average age of onset is around 60.
• Family History: Having a close relative with Parkinson disease increases the risk, suggesting a genetic component.
• Genetic Mutations: As mentioned earlier, specific gene mutations can increase the risk, particularly for early-onset Parkinson.
• Sex: Men are slightly more likely to develop Parkinson disease than women.
• Exposure to Certain Pesticides and Herbicides: Some studies have linked exposure to agricultural chemicals to an increased risk.
• Past Head Injury: Traumatic brain injury has been suggested as a possible risk factor.
• Living in Rural Areas: This may be related to increased exposure to pesticides or well water.

It's important to note that having one or more of these risk factors does not mean that a person will definitely develop Parkinson disease. Many people with these risk factors never develop the condition, and many people with Parkinson have none of these known risk factors.

Parkinson disease can lead to various complications as it progresses, affecting different aspects of an individual's health and well-being:

• Motor Complications: These include dyskinesia (involuntary movements), motor fluctuations (wearing-off of medication effects), and freezing of gait.
• Cognitive Decline: Mild cognitive impairment is common, and some individuals may develop Parkinson disease dementia, affecting memory, attention, and executive functions.
• Neuropsychiatric Issues: Depression, anxiety, apathy, hallucinations, and delusions can occur.
• Sleep Disorders: Insomnia, REM sleep behaviour disorder, and excessive daytime sleepiness are common.
• Swallowing Problems (Dysphagia): Can lead to malnutrition and aspiration pneumonia.
• Speech Problems (Dysarthria): Can make communication difficult.
• Balance Problems and Falls: Increase the risk of injuries.
• Constipation and Bowel Issues: Can significantly impact comfort and quality of life.
• Urinary Problems: Including urgency and incontinence.
• Pain and Fatigue: Can be chronic and debilitating.

Living with Parkinson disease requires adaptation, support, and proactive management. Here are some tips:

• Stay Active: Engage in regular exercise tailored to your abilities. This can help improve mobility, balance, and mood. Consult with a physical therapist for guidance.
• Maintain a Healthy Diet: Eat a balanced diet rich in fibre, fruits, and vegetables to support overall health and manage constipation. Ensure adequate hydration.
• Get Enough Sleep: Establish a regular sleep routine and address any sleep problems with your doctor.
• Manage Stress: Practice stress-reducing techniques such as mindfulness, meditation, or hobbies you enjoy.
• Stay Hydrated: Drink plenty of fluids throughout the day.
• Use Assistive Devices: Consider using aids like canes or walkers for balance support, and adaptive equipment for daily tasks.
• Communicate Effectively: Work with a speech therapist to address speech and swallowing difficulties.
• Seek Emotional Support: Connect with support groups, therapists, or friends and family for emotional support.
• Plan Ahead: Anticipate challenges and develop strategies to manage them, such as allowing extra time for tasks.
• Focus on What You Can Do: Maintain a positive attitude and focus on your strengths and abilities.

Myth: Parkinson disease only affects older people. 

While it is more common in older adults, young-onset Parkinson can occur in people under 50, and even younger than 40.

Myth: Tremor is the only symptom of Parkinson. 

While tremor is a hallmark symptom, Parkinson also involves other motor symptoms like rigidity and bradykinesia, as well as numerous non-motor symptoms.

Myth: Parkinson disease is fatal. 

Parkinson disease itself is not directly fatal, but complications from the disease, such as falls and pneumonia, can be life-threatening. With proper management, people with Parkinson can live for many years.

It is important to see a doctor if you experience any of the early signs of Parkinson disease, such as tremor, stiffness, slowness of movement, or balance problems. Early diagnosis and intervention can help manage symptoms and improve long-term outcomes. You should also consult your doctor if:

• Your symptoms worsen or change.
• You experience new symptoms.
• Your current treatment is not providing adequate relief.
• You are experiencing significant side effects from your medications.

Regular follow-up appointments with a neurologist specialising in movement disorders are essential for ongoing management of Parkinson disease.

• What are the typical symptoms of Parkinson disease?
• How is Parkinson disease diagnosed? Are there any specific tests?
• What stage of Parkinson disease am I in?
• What are the treatment options available for me?
• What are the potential side effects of these treatments?
• How will Parkinson disease progress over time?
• Are there any lifestyle changes I should make?
• What specialists might be involved in my care?
• What can I do to maintain my independence and quality of life?

• Encourage Social Engagement: Help them stay connected with friends and participate in activities they enjoy.
• Respect Their Independence: Avoid doing things for them that they can still do themselves.
• Be Flexible: Understand that their abilities and needs may change from day to day.
• Learn About Resources: Familiarise yourself with local support groups, therapists, and other resources that can provide assistance.
• Focus on Their Strengths: Encourage their abilities and celebrate their achievements.

Parkinson disease is a progressive neurological disorder that presents a unique set of challenges for affected individuals and their families. Characterised by motor symptoms such as tremor, rigidity, and bradykinesia, as well as a wide array of non-motor features, it requires a comprehensive and individualised approach to management. While a cure remains elusive, significant advancements in treatment and supportive care can help individuals live more fulfilling lives. Raising awareness, dispelling misconceptions, and fostering supportive communities are essential for empowering those living with Parkinson disease and their loved ones.